Literature DB >> 34296325

Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer.

Rosa M Jimenez-Rodriguez1, Jonathan B Yuval1, Charles-Etienne Gabriel Sauve1, Isaac Wasserman1, Piyush Aggarwal1, Paul B Romesser2, Christopher H Crane2, Rona Yaeger3, Andrea Cercek3, Jose G Guillem1, Martin R Weiser1, Iris H Wei1, Maria Widmar1, Garrett M Nash1, Emmanouil P Pappou1, Julio Garcia-Aguilar1, Marc J Gollub4, Philip B Paty5, J Joshua Smith6.   

Abstract

PURPOSE: To compare the characteristics and outcomes of rectal cancer patients with local recurrence at a perianastomotic site (PA), a surgical field (SF) site, or in lateral lymph nodes (LLN).
METHODS: A total of 114 consecutive patients who underwent surgery for recurrent, non-metastatic rectal cancer at a single comprehensive cancer center between 1997 and 2012 were grouped on the basis of radiographic assessment of type of recurrence: PA, 76 (67%) patients; SF, 25 (22%) patients; LLN, 13 (11%) patients. Demographic, clinical, and pathological features were compared between the three groups, as were disease-free survival (DFS) and overall survival (OS).
RESULTS: Recurrence type was associated with positive circumferential margin in the primary resection (PA, 4 [6%]; SF, 4 [19%]; LLN, 3 [25%]; P = 0.027), prior neoadjuvant therapy for the primary tumor (PA, 57 [75%]; SF, 18 [72%]; LLN, 4 [31%]; P = 0.007), and location of the primary tumor in the upper rectum (PA, 33 [45%]; SF, 5 [23%]; LLN, 1 [8%]; P < 0.001). Patients with PA had longer median DFS (PA, 5.1 years; SF, 1.5 years; LLN, 1.2 years; P = 0.036). There was a non-significant trend toward longer OS and higher rates of R0 resection for PA.
CONCLUSION: Type of recurrence after salvage surgery for locally recurrent rectal cancer is associated with longer DFS in patients with PA recurrence.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Rectal cancer; Recurrence; Salvage surgery; Survival

Mesh:

Year:  2021        PMID: 34296325      PMCID: PMC8923354          DOI: 10.1007/s00384-021-03998-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.796


  25 in total

1.  Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.

Authors:  K Yamada; T Ishizawa; K Niwa; Y Chuman; S Akiba; T Aikou
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

2.  Origin of presacral local recurrence after rectal cancer treatment.

Authors:  M Kusters; C Wallner; M M Lange; M C DeRuiter; C J H van de Velde; Y Moriya; H J T Rutten
Journal:  Br J Surg       Date:  2010-10       Impact factor: 6.939

Review 3.  Patterns of local recurrence in rectal cancer after a multidisciplinary approach.

Authors:  Jose M Enríquez-Navascués; Nerea Borda; Aintzane Lizerazu; Carlos Placer; Jose L Elosegui; Juan P Ciria; Adelaida Lacasta; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

4.  Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921.

Authors:  Jean-François Bosset; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Antoine Briffaux; Laurence Collette
Journal:  J Clin Oncol       Date:  2005-07-11       Impact factor: 44.544

5.  Feasibility of reirradiation in the treatment of locally recurrent rectal cancer.

Authors:  S J Bosman; F A Holman; G A P Nieuwenhuijzen; H Martijn; G-J Creemers; H J T Rutten
Journal:  Br J Surg       Date:  2014-07-22       Impact factor: 6.939

6.  Curative reoperations for locally recurrent rectal cancer.

Authors:  K Suzuki; R R Dozois; R M Devine; H Nelson; A L Weaver; L L Gunderson; D M Ilstrup
Journal:  Dis Colon Rectum       Date:  1996-07       Impact factor: 4.585

7.  Patterns of pelvic recurrence following definitive resections of rectal cancer.

Authors:  S J Pilipshen; M Heilweil; S H Quan; S S Sternberg; W E Enker
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

8.  Circumferential resection margin as a prognostic factor in rectal cancer.

Authors:  T E Bernstein; B H Endreseth; P Romundstad; A Wibe
Journal:  Br J Surg       Date:  2009-11       Impact factor: 6.939

9.  Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results.

Authors:  Luca Sorrentino; Filiberto Belli; Francesca Valvo; Sergio Villa; Marcello Guaglio; Davide Scaramuzza; Alessandro Gronchi; Maria Di Bartolomeo; Maurizio Cosimelli
Journal:  Surg Oncol       Date:  2020-08-20       Impact factor: 3.279

10.  Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.

Authors:  Arne Wibe; Astri Syse; Elisabeth Andersen; Steinar Tretli; Helge E Myrvold; Odd Søreide
Journal:  Dis Colon Rectum       Date:  2004-01-14       Impact factor: 4.585

View more
  2 in total

Review 1.  The importance of MRI for rectal cancer evaluation.

Authors:  Maria Clara Fernandes; Marc J Gollub; Gina Brown
Journal:  Surg Oncol       Date:  2022-03-18       Impact factor: 2.388

2.  Practical Application of Augmented/Mixed Reality Technologies in Surgery of Abdominal Cancer Patients.

Authors:  Vladimir M Ivanov; Anton M Krivtsov; Sergey V Strelkov; Anton Yu Smirnov; Roman Yu Shipov; Vladimir G Grebenkov; Valery N Rumyantsev; Igor S Gheleznyak; Dmitry A Surov; Michail S Korzhuk; Valery S Koskin
Journal:  J Imaging       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.